3MS9
ABL kinase in complex with imatinib and a fragment (FRAG1) in the myristate pocket
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2006-08-11 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 1.0000 |
Spacegroup name | F 2 2 2 |
Unit cell lengths | 115.783, 147.346, 152.833 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.920 - 1.800 |
R-factor | 0.18794 |
Rwork | 0.186 |
R-free | 0.23391 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.026 |
RMSD bond angle | 1.986 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | REFMAC |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.920 | 1.880 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.065 | 0.365 |
Number of reflections | 58848 | |
<I/σ(I)> | 11.38 | 2.58 |
Completeness [%] | 97.6 | 83.3 |
Redundancy | 4 | 2.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 277 | protein concentration: 20mg/ml. Crystallisation buffer: 0.1M MES pH 6.5, 0.2M MgCl2, 18.4% PEG4000, VAPOR DIFFUSION, temperature 277K |